Janssen (Johnson & Johnson): Jcovden

Vaccine Type: Non Replicating Viral Vector

This vaccine may also be referred to as Ad26.COV2.S, Ad26COVS1, JNJ-78436735

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 6 Trials

Phase 2: 12 Trials

Phase 3: 8 Trials

Registered Trials